Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Monique Carter"'
1
Akademický článek
Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)
Autor: Madhura Joglekar-Javadekar, Steven Van Laere, Michael Bourne, Manal Moalwi, Pascal Finetti, Peter B. Vermeulen, Daniel Birnbaum, Luc Y. Dirix, Naoto Ueno, Monique Carter, Justin Rains, Abhijit Ramachandran, Francois Bertucci, Kenneth L. van Golen
Publikováno v: Neoplasia: An International Journal for Oncology Research, Vol 19, Iss 7, Pp 564-573 (2017)
PURPOSE: Inflammatory breast cancer (IBC) is arguably the deadliest form of breast cancer due to its rapid onset and highly invasive nature. IBC carries 5- and 10-year disease-free survival rates of ~45% and
Externí odkaz: https://doaj.org/article/75c90e96945a459bb985cf9daa5b60e4
Zobrazit plný text záznamu
3
Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)
Autor: Kenneth L. van Golen, Steven Van Laere, Daniel Birnbaum, Abhijit Ramachandran, Madhura Joglekar-Javadekar, Justin Rains, Monique Carter, Pascal Finetti, François Bertucci, Manal Moalwi, Luc Dirix, Naoto T. Ueno, Peter B. Vermeulen, Michael Bourne
Publikováno v: Neoplasia
Neoplasia, 2017, 19 (7), pp.564-573. ⟨10.1016/j.neo.2017.03.002⟩
Neoplasia, Elsevier, 2017, 19 (7), pp.564-573. ⟨10.1016/j.neo.2017.03.002⟩
Neoplasia: An International Journal for Oncology Research, Vol 19, Iss 7, Pp 564-573 (2017)
International audience; PURPOSE: Inflammatory breast cancer (IBC) is arguably the deadliest form of breast cancer due to its rapid onset and highly invasive nature. IBC carries 5-and 10-year disease-free survival rates of ~45% and b20%, respectively.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c52791f612d4a17e2c3a1b95a2856c44
https://hal.science/hal-01789694/file/Joglekar-Javadekar_Neoplasia_2017.pdf
Zobrazit plný text záznamu
5
Abstract P6-12-15: Preclinical testing of a novel platelet derived growth factor receptor alpha (PDGFRa) inhibitor in inflammatory breast cancer
Autor: Madhura Joglekar, L.Y. Dirix, Peter B. Vermeulen, Monique Carter, A Rhamchandran, K van Golen, S. Van Laere
Publikováno v: Cancer Research. 73:P6-12
Inflammatory breast cancer (IBC) is the most lethal form of locally advanced breast cancer and carries a guarded prognosis. IBC presents with a “lumpless” primary tumor, which rapidly infiltrates and forms tumor emboli within the dermal lymphatic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::418106171946d513556646fe6f0722e7
https://doi.org/10.1158/0008-5472.sabcs13-p6-12-15
Zobrazit plný text záznamu
6
Hox and a Newly Identified E2F Co-repress Cell Death in Caenorhabditis elegans
Autor: Scott Cameron, Leon Avery, Jennifer Winn, Monique Carter
Publikováno v: Genetics. 188:897-905
The development of an organism depends on individual cells receiving and executing their specific fates, although how this process is regulated remains largely unknown. Here, we identify a mechanism by which a specific cell fate, apoptosis, is determ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d69a6c1fed4966f53ceee28bc59c7925
https://doi.org/10.1534/genetics.111.128421
Zobrazit plný text záznamu
7
Abstract 4282: Crenolanib inhibition of PDGFRA+ fibroblast-like cells in visceral smooth muscle
Autor: Sean M. Ward, Evan Colletti, Abhijit Ramachandran, Monique Carter
Publikováno v: Cancer Research. 73:4282-4282
Platelet derived growth factors (PDGFs) and their receptors (PDGFRs) play important roles in cell proliferation, survival, and migration . The PDGF/PDGFR signaling pathway plays a crucial role in embryonic development and for interstitial and mesench
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7fa960f1718c397d6a2ee6ce173a56a6
https://doi.org/10.1158/1538-7445.am2013-4282
Zobrazit plný text záznamu
8
Abstract 1035: Crenolanib, a highly selective platelet-derived growth factor receptor α/β (PDGFRA/B) tyrosine kinase inhibitor, destabilizes ETV1 protein in KIT-mutant gastrointestinal stromal tumor (GIST) cells
Autor: Monique Carter, Brian P. Rubin, Michael R. Bardsley, Takahiro Taguchi, Yujiro Hayashi, Yoshitaka Toyomasu, Abhijit Ramachandran, Tamas Ordog
Publikováno v: Cancer Research. 73:1035-1035
Background & Aims: Most GIST harbor oncogenic KIT or PDGFRA mutations, which are in most cases heterozygous. However, most GIST co-express both wild-type KIT and PDGFRA with the mutated KIT or PDGFRA. Signaling mediated by heterodimers of the wild-ty
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bc3a486e3123b06b37517cb925595352
https://doi.org/10.1158/1538-7445.am2013-1035
Zobrazit plný text záznamu
9
Abstract 172: Predictors of breast cancer clinical trial participation by logistic regression analysis in minority women residing in medically underserved regions
Autor: Monique Carter, Tracy A. Davis
Publikováno v: Cancer Research. 73:172-172
Background Enrollment investigation literature estimates that 3% of newly diagnosed breast cancer patients participate in clinical trials annually in the United States. Participation levels decrease significantly when varied by race and geographic lo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::455fdc49d38ab18f312e9ab1124b5a20
https://doi.org/10.1158/1538-7445.am2013-172
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje